glutathione for heart disease Reduced serum level in patients with various stages of Glutathione's role in heart health

Whos Most at Risk of Low B12

Similarly, the combined detection of SDC2-SEPTIN9-VIM has the potential to serve as a biomarker for early diagnosis of CRC (Yuan et al., 2022)

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

For patients & payers: A step toward lower costs and broader access to proven obesity treatments For Teva Pharmaceuticals: A strategic move into one of the fastest-growing segments in global pharma For Novo Nordisk: Limited short-term impact, but mounting competitive pressure as generics gain ground This development could reshape affordability, accessibility, and competition in obesity care signaling the beginning of a new chapter for patients and healthcare systems worldwide